Drug Profile
Universal influenza vaccine - iQur
Latest Information Update: 06 Sep 2023
Price :
$50
*
At a glance
- Originator iQur
- Class Influenza virus vaccines; Virus-like particle vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Influenza A virus infections; Influenza B virus infections
Most Recent Events
- 06 Sep 2023 Universal influenza vaccine is still in preclinical development for Influenza-A-virus-infections and Influenza-B-virus-infections (Prevention) in United Kingdom (iQur pipeline, September 2023)
- 28 Feb 2023 No recent reports of development identified for preclinical development in Influenza-A-virus-infections(Prevention) in United Kingdom (Parenteral)
- 28 Feb 2023 No recent reports of development identified for preclinical development in Influenza-B-virus-infections(Prevention) in United Kingdom (Parenteral)